Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
The FDA has recognized seven years of orphan-drug exclusivity for ONAPGO (apomorphine HCl) for the treatment of motor fluctuations in advanced Parkinson’s disease. The exclusivity period is retroactive to the drug's approval date of February 3, 2025, and the company has also submitted an sNDA for a second supplier to ensure long-term supply stability.
Term
7 years
“Securing orphan-drug exclusivity marks an important milestone for individuals and families navigating Parkinson's disease. This designation validates the urgent need for targeted therapies and helps safeguard continued innovation in a long-underserved community.”
Jack Khattar, President and Chief Executive Officer of Supernus Pharmaceuticals
TruGolf Holdings, Inc. announced that it believes it has regained compliance with Nasdaq's $2.5 million minimum stockholders' equity requirement following the completion of its acquisition of Polymath Research Inc. and a $2.95 million Series B preferred stock financing. Nasdaq will continue to monitor the company's compliance through its next periodic report to ensure the requirement remains satisfied.
Reborn Coffee Wins $30M Contract from Visvita Corporation
Reborn Coffee entered into a Master Product Supply Agreement with Visvita Corporation to supply aloe vera and other beverage products, targeting a first-year business volume of $30 million. An initial $2 million purchase order has already been secured, with Reborn Coffee managing logistics through its subsidiary, Reborn Logistics.
Value
$30M
Counterparty
Visvita Corporation
Term
2 years
“This agreement converts a framework into contracted volume and puts the freight economics in our hands. We set the supply price and the margin on every order, and plan to move the freight through Reborn Logistics instead of outside providers. That combination is what we believe turns a $30 million volume target into margin rather than revenue alone.”
Jung Jae Lim, Chief Executive Officer of Reborn Coffee
“As Head of Global Sales Advisory for Reborn Coffee, I plan to mobilize our distribution network to establish Reborn’s signature matcha latte, milk coffee and other key products in the market. We will dedicate our full efforts to the complete fulfillment of the $30 million annual minimum purchase target.”
Michael Aminpour, President of Visvita Corporation and Head of Global Sales Advisory for Reborn Coffee
Leslie’s, Inc. and its subsidiaries filed a Joint Plan of Reorganization and Disclosure Statement in the U.S. Bankruptcy Court to implement a pre-arranged Chapter 11 restructuring. The plan is supported by a Restructuring Support Agreement (RSA) with Consenting Term Loan Lenders to address the company's debt obligations. As a result of the bankruptcy filing and minimum bid price deficiencies, the company's common stock has been suspended from Nasdaq and transitioned to the Pink Limited Market under the symbol LESLQ.
Fortress Private Lending Fund Capital Raise of $14.3M
Fortress Private Lending Fund sold 592,007 Class I common shares in an unregistered private placement for aggregate proceeds of $14.3 million. The shares were sold to accredited investors at a price of $24.2145 per share, which represents the company's net asset value as of September 30, 2026.
MSD Investment Corp. completed a capital drawdown from its stockholders, issuing 6,334,459 shares of common stock for approximately $150 million. The issuance was conducted via private placement under subscription agreements where stockholders fund capital commitments on an as-needed basis.
Drugs Made In America Acquisition Signs $1.71B M&A Deal with Power Analytics Global Corp
Drugs Made In America Acquisition Corp. entered into an amendment to its merger agreement with Power Analytics Global Corp (PAGC) to establish a standalone closing valuation of $1.71 billion. This valuation applies if PAGC's acquisition of APQC Inc is not completed by November 1, 2026, down from the original $2.85 billion valuation that included the APQC assets. The merger consideration will be paid entirely in shares at the closing with no earnout provisions.
Forge Nano Holdings M&A Deal with Archimedes Tech SPAC Partners II Co.
Forge Nano, Inc. has completed its business combination with Archimedes Tech SPAC Partners II Co., a special purpose acquisition company. The combined entity will operate as Forge Nano Holdings, Inc. and is expected to begin trading on the Nasdaq under the ticker symbol 'NANO' on October 22, 2026. The transaction follows a shareholder vote where holders of approximately 22.2 million shares exercised redemption rights for $238.4 million.
Counterparty
Archimedes Tech SPAC Partners II Co.
“Becoming a publicly traded company represents an important milestone for Forge Nano and the team that has spent more than a decade building this company. We founded Forge Nano around the belief that controlling materials at the atomic level could fundamentally improve how the world’s most important technologies are made. Today, that technology is moving into commercial semiconductor manufacturing, advanced batteries and other critical applications. Access to the public markets gives us an opportunity to accelerate that work and continue scaling an American advanced manufacturing company built for the industries that will define the next generation.”
Paul Lichty, Chief Executive Officer of Forge Nano
Direct Digital Holdings Nasdaq/NYSE Compliance Notice
Direct Digital Holdings, Inc. has notified Nasdaq of its intention to voluntarily delist its Class A common stock and deregister with the SEC. The decision follows a prior delisting determination from Nasdaq on October 1, 2026, due to the company's failure to comply with minimum listing requirements, which resulted in a trading suspension on October 5, 2026.
Super League Enterprise, Inc. increased the capacity of its existing at-the-market (ATM) offering program by $0.95 million. The total aggregate offering amount under the sales agreement with The Benchmark Company and StoneX Financial now stands at $6.42 million.
Integrated Rail & Resources Capital Raise of $944K
Integrated Rail & Resources Inc. entered into a securities purchase agreement with Huntington Oil & Gas III, LLC for the sale of 9,444 shares of Series A Convertible Preferred Stock at $100.00 per share. The financing is contingent on a concurrent $600,000 investment from Creto IRRX PIPE Investment, LLC. Proceeds will be used for operational purposes and to advance the development of the company's Vernal refinery.
Integer Holdings M&A Deal with Kohlberg Kravis Roberts & Co. L.P.
Stockholders of Integer Holdings Corporation (ITGR) have approved the company's acquisition by affiliates of KKR. The transaction, originally announced in August 2026, is expected to close by the end of 2026 subject to regulatory approvals and customary closing conditions.
Soluna Holdings Partnership with Applied Digital Corporation Worth $38.3M
Soluna Holdings entered into a subscription agreement with Applied Digital Corporation to form a joint venture to develop a 50 megawatt data center for AI and high-performance computing at Project Dorothy 3 in Texas. Applied Investor will contribute $19.5 million in cash for a 51% stake, while Soluna Investor will contribute a ground sublease valued at $18.75 million for a 49% stake. The closing of the transaction is expected to occur on or before December 1, 2026.
Stepstone Private Credit Fund Capital Raise of $54.8M
StepStone Private Credit Fund LLC sold 2,123,951 unregistered shares for $54.8 million as part of its ongoing continuous private offering. The company also reported a preliminary September 30, 2026 net asset value of $25.81 per share and a Q3 2026 distribution of $0.57 per share.
T1 Energy Signs $133M M&A Deal with Evervolt Green Energy Holding Pte, Ltd.
T1 Energy Inc. issued 9,962,645 shares of common stock to Evervolt Green Energy Holding Pte, Ltd. to satisfy a $30.0 million payment tranche for the acquisition of intellectual property assets. The issuance is part of a larger $133.0 million IP purchase agreement originally signed in July 2026, with share delivery currently deferred due to a 4.99% beneficial ownership limitation.
International Seaways M&A Deal with Bruton Limited
International Seaways completed exchange transactions to acquire a 50.5% controlling interest in Bruton Limited from certain shareholders. In exchange for their Bruton common shares, the participating shareholders received an aggregate of 1,624,036 shares of International Seaways common stock.
Alpha Teknova, Inc. entered into an underwriting agreement for a public offering of 8,000,000 shares of common stock at $5.00 per share, generating $40 million in gross proceeds. The company granted underwriters a 30-day option to purchase up to 1,200,000 additional shares and intends to use the proceeds for general corporate purposes and potential debt repayment.
Ares Core Infrastructure Fund Capital Raise of $769M
Ares Core Infrastructure Fund raised $768.9 million in gross proceeds through the sale of approximately 31.1 million common shares in its October 2026 monthly closing. The shares were issued at a price of $24.7489 per share, which corresponds to the Fund's net asset value as of September 30, 2026.
Alaunos Therapeutics received a delisting notice from Nasdaq on October 5, 2026, due to continued non-compliance with the $2.5 million minimum stockholders' equity requirement. The company has requested a hearing before the Nasdaq Hearings Panel, currently scheduled for November 10, 2026, which has stayed any delisting action pending the outcome.
Quanome Technologies, Inc. entered into an At The Market (ATM) Offering Agreement with Maxim Group LLC to sell up to $9,754,475 of its common stock. The company intends to use any net proceeds for working capital, general corporate purposes, and potential strategic acquisitions. Maxim Group will receive a 3.0% commission on the gross sales price of any shares sold under the facility.
Remora Capital Corporation issued 106,974.359 shares of common stock to investors at a price of $9.75 per share. The private placement resulted in aggregate proceeds of approximately $1.043 million and was conducted under a Section 4(a)(2) exemption.
QuantumScape announced a strategic ecosystem partnership with Muehlbauer Group to provide cell assembly equipment for a planned 100 megawatt-hour (MWh) commercial-scale mass production line. The partnership aims to scale QuantumScape's solid-state cell technology from the current Eagle Line pilot phase toward gigawatt-hour scale production, with the 100-MWh line targeted for 2028.
Ares Sports, Media & Entertainment Opportunities Capital Raise of $77M
Ares Sports, Media and Entertainment Opportunities LP sold unregistered limited partnership units for aggregate consideration of approximately $77.0 million on October 1, 2026. The sale was part of the Fund's continuous private offering, which has raised approximately $988 million in total cash consideration to date.
Professional Diversity Network entered into securities purchase agreements to sell 146,713 shares of common stock in a private placement for gross proceeds of approximately $250,000. The shares are priced at $1.704 per share, representing a 40% discount to the recent closing price, with the closing expected to occur on or around November 3, 2026.
Ionis Pharmaceuticals' partner GSK received FDA approval for HIBSAGO (bepirovirsen) for the treatment of chronic hepatitis B (CHB) in adult patients without cirrhosis. The approval, granted under priority review and Breakthrough Therapy Designation, is based on Phase 3 B-Well trials showing a 19% functional cure rate compared to less than 1% for standard of care. Ionis is eligible to receive regulatory and sales milestone payments plus tiered royalties of 10-12% on net sales.
Valor Energy Inc received a deficiency notice from Nasdaq for failing to meet the minimum stockholders' equity requirement of $2.5 million. The company reported a stockholders' deficit of $35.3 million as of June 30, 2026, primarily due to the classification of warrants as derivative liabilities. The company has 45 days to submit a plan to regain compliance.
KKR FS Income Trust Select issued and sold 136,926.789 Class I shares for aggregate consideration of approximately $3.404 million on October 1, 2026. The sale was part of the company's ongoing continuous private offering, which has raised approximately $1.045 billion to date against a $5.0 billion target.
KKR FS Income Trust issued and sold 146,235.262 Class I shares for aggregate consideration of approximately $4.259 million on October 1, 2026. The sale was part of the company's ongoing continuous private offering, which has raised approximately $1.773 billion to date against a $5.0 billion target.
First Mid Bancshares M&A Deal with EPL LINCO Trust
First Mid Bancshares, Inc. entered into an amendment to a registration rights agreement with EPL LINCO Trust and PL Generations LLC. The amendment facilitates the potential secondary resale of shares previously issued as consideration for the acquisition of LINCO Bancshares, Inc. by adding PL Generations as a permitted transferee.
Stone Point Credit Income Fund Capital Raise of $41.2M
Stone Point Credit Income Fund issued and sold approximately 1.66 million common shares through capital drawdown notices to investors, raising total proceeds of approximately $41.18 million. The shares were sold at a net asset value of $24.7338 per share to investors under existing subscription agreements. To date, the Fund has received total capital commitments of $1.19 billion, with approximately $736.5 million remaining unfunded.